Shares of ValiRx plc (LON:VAL – Get Free Report) crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of GBX 0.14 and traded as high as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 20,712,516 shares trading hands.
ValiRx Stock Performance
The company’s fifty day moving average price is GBX 0.14 and its 200-day moving average price is GBX 0.23. The stock has a market cap of £1.93 million, a P/E ratio of -0.36 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) EPS for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. Analysts anticipate that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
